2004
DOI: 10.1007/s00769-003-0734-5
|View full text |Cite
|
Sign up to set email alerts
|

Comprehensive quality control programme for serology and nucleic acid testing using an Internet-based application

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 0 publications
0
11
0
Order By: Relevance
“…initial and repeat reactor rates) [1]. The performance of assays found suitable for blood screening in evaluations can vary over time due to changes in reagent batches [12], instruments [1,11,19] or operators [19,23] and due to inadequate transport or storage conditions. Generally, laboratories do not use the same batch of kit (Internal) controls over a long period of time and therefore long‐term monitoring of assay performance using the results of kit controls is not possible.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…initial and repeat reactor rates) [1]. The performance of assays found suitable for blood screening in evaluations can vary over time due to changes in reagent batches [12], instruments [1,11,19] or operators [19,23] and due to inadequate transport or storage conditions. Generally, laboratories do not use the same batch of kit (Internal) controls over a long period of time and therefore long‐term monitoring of assay performance using the results of kit controls is not possible.…”
Section: Discussionmentioning
confidence: 99%
“…Data were submitted into a single database using a real‐time, Internet‐based application, EDCNet (http://www.nrlqa.net). This application was developed by the NRL and implemented in 2001 [12,20,23].…”
Section: Methodsmentioning
confidence: 99%
“…In infectious disease serology, such as the detection of anti-HIV antibodies, the paradigm above does not apply [21,23]. There are generally no CRM to facilitate quantification; the exception being analytes such as antihepatitis B surface antigen and anti-rubella IgG [12].…”
Section: Numbermentioning
confidence: 96%
“…Serological assays used to test for infectious diseases often experience considerable variation associated with the introduction of new assay lot numbers [12,23,24,41]. Therefore, after setting control limits using the traditional method of determining the mean ± 2 or 3 times the SD from a previous approximately 20 QC sample results, subsequent results frequently fall outside these control limits when a new assay lot number is introduced.…”
Section: Numbermentioning
confidence: 97%
See 1 more Smart Citation